2011-10-26T10:22:00-05:00 2010-12-31 TATE AND TRYON 2021 L STREET NW SUITE 400 WASHINGTON DC 20036 990 2010-01-01 136180380 AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC AMER 5714831300 2318 MILL ROAD NO 800 ALEXANDRIA VA 22314 PAUL AINES 5714831300 2011-10-25 1 DEBORAH G KOSNETT 2022932200 2010 2016-03-07 17:11:31Z ALLEN LICHTER MD 2318 MILL ROAD NO 800 ALEXANDRIA VA 22314 92510163 0 X WWW.ASCO.ORG X 1964 NY ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY PATIENT CARE. 18 16 304 1200 8404587 1661960 9749125 8931139 66377111 70399472 -1105029 761935 -72501 -537553 74948706 79554993 1594664 1766751 0 0 25300083 26424110 45000 193150 2737748 43160135 41452554 70099882 69836565 4848824 9718428 140004159 157835906 90434447 93957853 49569712 63878053 X GOAL STATEMENTS: ADVANCE THE EDUCATION OF THE ONCOLOGY COMMUNITY. ADVOCATE PUBLIC POLICY TO ENSURE PATIENTS THE BENEFITS OF ONGOING RESEARCH AND HIGH QUALITY CARE AND ASSIST ONCOLOGISTS GLOBALLY IN OFFERING CANCER PATIENTS THE BEST POSSIBLE OUTCOMES. ASCO VISION STATEMENTS:-- ALL CANCER PATIENTS WILL HAVE LIFELONG ACCESS TO HIGH QUALITY, EFFECTIVE, AFFORDABLE AND COMPASSIONATE CARE.-- THE MOST ACCURATE CANCER INFORMATION WILL BE AVAILABLE SO THAT PATIENTS AND PHYSICIANS CAN MAKE INFORMED DECISIONS ABOUT CANCER PREVENTION AND TREATMENT.-- INFORMATION WE LEARN FROM EVERY PATIENT WILL BE USED TO ACCELERATE PROGRESS AGAINST CANCER.-- RESOURCES WILL EXIST TO ATTRACT THE BEST CLINICIANS AND INVESTIGATORS TO PROVIDE OPTIMAL PATIENT CARE AND TO CONDUCT TRANSFORMATIVE RESEARCH. --ASCO WILL BE RECOGNIZED AS THE MOST TRUSTED SOURCE OF CANCER INFORMATION WORLDWIDE. 1 0 31837975 461163 36140116 EDUCATIONAL AND SCIENTIFIC MEETINGS AND PRODUCTS AND PROFESSIONAL DEVELOPMENT: ASCO PROVIDES EDUCATIONAL AND SCIENTIFIC PROGRAMS AND CONTENT ON A WIDE VARIETY OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF DIFFERENT FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON CUTTING EDGE RESEARCH AND SCIENCE IN THE FIELD OF CLINICAL ONCOLOGY. THE SCIENTIFIC RESEARCH AND EDUCATION PRESENTED AT THE MEETINGS ENHANCE KNOWLEDGE ABOUT CANCER, THUS ADVANCING HIGH-QUALITY CANCER CARE.THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER EDUCATIONAL AND SCIENTIFIC MEETING IN THE ONCOLOGY COMMUNITY AND THE THEMATIC MEETINGS PRESENTED OR CO-SPONSORED BY ASCO PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC PROGRAMMING ON SPECIFIC TYPES OF CANCERS. ASCO'S EDUCATIONAL AND SCIENTIFIC PROGRAMS SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE AND THROUGH THE CONTINUUM OF THEIR CAREERS. APPROPRIATE PROGRAMS ARE PROVIDED FOR ONCOLOGY FELLOWS, JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, AND OTHERS TO MEET THE CHANGING NEEDS OF PEOPLE LIVING WITH CANCER AND ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS SO THAT THEY ARE BETTER PREPARED TO MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY, ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM.ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT AVAILABLE TO THE GENERAL PUBLIC THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES EDUCATIONAL AND SCIENTIFIC MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS. HIGHLIGHTS OF THE 2010 ACTIVITIES INCLUDE: APPROXIMATELY 33,000 PEOPLE ATTENDED THE 2010 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES, CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. MORE THAN HALF OF ATTENDEES AT THE 2010 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2010 ANNUAL MEETING FEATURED OVER 250 EDUCATIONAL AND SCIENTIFIC SESSIONS AND OVER 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. OVER 1,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY.-- IN 2010, ASCO WAS THE LEAD SPONSOR OF SEVERAL THEMATIC SYMPOSIA FOCUSING ON GENITOURINARY CANCERS, GASTROINTESTINAL CANCERS, BREAST CANCER, AND MOLECULAR MARKERS, COLLECTIVELY DRAWING OVER 7,100 ATTENDEES. THESE THEMATIC SYMPOSIA WERE OPEN TO THE GENERAL PUBLIC. -- IN 2010, ASCO SPONSORED OR CO-SPONSORED OVER 30 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE IN (AND) AROUND THE WORLD. THESE MEETINGS INCLUDE: -- ANNUAL MEETING -- GI SYMPOSIUM -- GU SYMPOSIUM -- BREAST CANCER SYMPOSIUM -- MOLECULAR MARKERS -- BEST OF ASCO BOSTON -- BEST OF ASCO SAN FRANCISCO -- ASCO/AACR METHODS WORKSHOPINTERNATIONAL AFFAIRS MEETINGS AND COURSES -- BEST OF ASCO INTERNATIONAL ( 11) -- JOINT SYMPOSIA (8) -- MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (2) -- ADVANCED CANCER COURSES (3)ASCO PUBLISHES ASCO DAILY NEWS, THE OFFICIAL NEWSPAPER OF THE ASCO ANNUAL MEETING, WHICH IS DISTRIBUTED WITHOUT CHARGE TO ANNUAL MEETING ATTENDEES AND ONLINE WORLDWIDE. ASCO DAILY NEWS INCLUDES COVERAGE OF KEY EDUCATIONAL AND SCIENTIFIC SESSIONS, EDITORIALS BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND COMMENTARY AND TOPICS OF INTEREST TO INTERNATIONAL ATTENDEES AND MEMBERS. 10655169 100000 23828147 EDUCATIONAL PUBLICATIONS: ASCO PUBLISHES TWO EDUCATIONAL JOURNALS ADDRESSING CLINICAL ONCOLOGY THAT ARE AVAILABLE TO THE PUBLIC. JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JCO INCLUDES ORIGINAL REPORTS, SELECTED EDITORIALS, COMMENTARIES, REVIEWS, AND OTHER WORK THAT RELATE TO THE CARE OF PATIENTS WITH CANCER. JCO IS TRANSLATED INTO A NUMBER OF LANGUAGES IN INTERNATIONAL EDITIONS, THEREBY INCREASING ITS USE INTERNATIONALLY.PROGRAM SERVICE ACCOMPLISHMENTS: JOURNAL OF ONCOLOGY PRACTICE (JOP) INCLUDES ORIGINAL RESEARCH, FEATURES ARTICLES, AND COLUMNS ON CLINICAL AND ADMINISTRATIVE MANAGEMENT FOR PRACTICING ONCOLOGISTS, WHICH ARE EDITED BY ONCOLOGISTS.IN 2010, THE JOURNAL OF CLINICAL ONCOLOGY HAD 24,300 ANNUAL SUBSCRIBERS. ADDITIONALLY, THE JCO IMPACT FACTOR INCREASED FOR A FOURTH CONSECUTIVE YEAR, AS REPORTED BY THOMSON REUTERS IN ITS 2009 JOURNAL CITATION REPORT. THE RISE IN THE IMPACT FACTOR OF NEARLY 50% SINCE 2005 IS A REFLECTION OF THE VALUE RESEARCHERS FIND IN JCO CONTENT. 8859900 402989 31631 CANCER POLICY AND CLINICAL AFFAIRS: ASCO'S CANCER POLICY AND CLINICAL AFFAIRS DEPARTMENT REPRESENTS THE INTERESTS OF PHYSICIANS, RESEARCHERS AND OTHER PROFESSIONALS INVOLVED IN CANCER RESEARCH, CARE AND PREVENTION. THE DEPARTMENT WORKS WITH VOLUNTEER COMMITTEES AND ASCO LEADERS TO SHAPE POLICY, LAW AND REGULATION ON ISSUES OF IMPORTANCE TO ASCO'S MEMBERS. THE DEPARTMENT'S PROGRAMS SPAN A BROAD SPECTRUM OF ISSUES, INCLUDING PATIENT-ORIENTED RESEARCH, CLINICAL PRACTICE, EVIDENCE-BASED GUIDELINES AND TECHNOLOGY ASSESSMENTS, QUALITY ASSESSMENT/IMPROVEMENT, WORKFORCE, DISPARITIES, COST/ACCESS, AND CANCER PREVENTION AND CONTROL. ACTIVITIES INCLUDE DIRECT SUPPORT TO MEMBERS SUCH AS HOTLINES, TOOLS AND LEGAL ANALYSIS, EDUCATIONAL WORKSHOPS AND MATERIALS, LEGAL ANALYSIS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY.CANCER POLICY AND CLINICAL AFFAIRS STAFF INTERACT AND COLLABORATE ON A REGULAR BASIS WITH ASCO STATE AND REGIONAL AFFILIATES, OTHER MEDICAL SPECIALTY AND PROFESSIONAL SOCIETIES, CONGRESS, THE ADMINISTRATION, AND PATIENT ADVOCATE ORGANIZATIONS TO ADVANCE COMMON GOALS RELATED TO CANCER RESEARCH AND QUALITY CARE. PROGRAM SERVICE ACCOMPLISHMENTS: IN 2010, ASCO'S ACTIVITIES INCLUDED EFFORTS IN THE FOLLOWING AREAS:1. NEW GUIDELINES AND ONGOING UPDATES: ASCO NOW HAS 28 PUBLISHED PRACTICE GUIDELINES ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES. AN ADDITIONAL 4 GUIDELINES ARE IN DEVELOPMENT, ALONG WITH 8 UPDATES TO EXISTING GUIDELINES. 2. QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI): A QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. THE PROGRAM IS UNIQUE IN THE CANCER COMMUNITY AND HAS BEEN ACCEPTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE AS A MECHANISM FOR SATISFYING PRACTICE EVALUATION AND IMPROVEMENT REQUIREMENTS FOR MAINTENANCE OF CERTIFICATION. ASCO SUPPORTS A NUMBER OF COLLABORATIVE GROUPS THAT USE QOPI WITHIN THEIR INITIATIVES TO DRIVE THEIR QUALITY IMPROVEMENT EFFORTS. OVER 700 PRACTICES NATIONWIDE, INCLUDING HAWAII, ALASKA, GUAM, AND PUERTO RICO ARE ENROLLED IN THE PROGRAM. 3. ADVANCED CANCER CARE: ASCO PUBLISHED A POSITION PAPER ON COMMUNICATION AND DECISION MAKING FOR PATIENTS WITH ADVANCED CANCER. THE PAPER OUTLINES THE GOALS FOR INDIVIDUALIZED CARE, BARRIERS THAT CURRENTLY LIMIT REALIZATION OF THIS VISION, AND POSSIBLE STRATEGIES TO OVERCOME THESE BARRIERS THAT CAN IMPROVE CARE CONSISTENT WITH THE WISHES OF PATIENTS AND EVIDENCE-BASED MEDICINE. 4. THE STATE/REGIONAL AFFILIATE PROGRAM: THE AFFILIATE PROGRAM WAS CREATED IN 1993 TO BETTER SERVE THE NEEDS OF COMMUNITY ONCOLOGISTS, AND TO FACILITATE ASCO'S OWN ADVOCACY PROGRAMS. THE 47 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE CLINICAL PRACTICE COMMITTEE (CPC), WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. THE MEMBER AFFILIATES HAVE ACCESS TO A NUMBER OF BENEFITS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, CME ACCREDITATION THROUGH JOINTLY SPONSORED EDUCATIONAL SESSIONS, FEDERAL- AND STATE-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND WEBSITE DEVELOPMENT.5. CODING, REIMBURSEMENT, AND COVERAGE POLICY: ASCO REVIEWS AND FREQUENTLY COMMENTS UPON CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) POLICIES AND PROGRAMS AFFECTING ONCOLOGY. STAFF AND VOLUNTEERS ALSO ACTIVELY PARTICIPATE IN AMERICAN MEDICAL ASSOCIATION (AMA) PROCESSES FOR DEVELOPMENT OF NEW CPT CODES AND VALUATION OF CODES THROUGH THE AMA/SPECIALTY SOCIETY RELATIVE VALUE SCALE UPDATE COMMITTEE (RUC). 3206791 344075 10574306 MEMBER SERVICES: MEMBER SERVICES WORKS TO SUPPORT ASCO'S MORE THAN 30,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND E-MAIL COMMUNICATIONS, RESEARCHING AND FULFILLING MEMBER REQUESTS, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS.ASCO CONNECTION IS THE QUARTERLY MAGAZINE FOR AND ABOUT MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY. IT IS THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS, BENEFITS, AND RESOURCES. TOGETHER WITH ITS COMPANION SOCIAL NETWORKING SITE, ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND BETWEEN MEMBERS AND THEIR COLLEAGUES. COMMUNICATIONS AND PATIENT INFORMATION: ASCO PROVIDES THE PUBLIC, INCLUDING PATIENTS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS WITH ACCURATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY.ASCO HAS A FREE PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), AVAILABLE TO THE PUBLIC, INCLUDING PATIENTS, THEIR CAREGIVERS, FAMILY MEMBERS AND FRIENDS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS THAT PROVIDES UP-TO-DATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, SURVIVORSHIP, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. THE SITE OFFERS MEDICAL INFORMATION ON MORE THAN 120 TYPES OF CANCER AND RELATED SYNDROMES, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, AND HOW TO COPE WITH THE EMOTIONAL AND SOCIAL EFFECTS OF LIVING WITH CANCER. IN ADDITION TO ITS WEBSITE CONTENT, ASCO OFFERS PRINTED MATERIALS FOR PATIENTS, SUCH AS: CANCER.NET'S GUIDES TO CANCER (DETAILED GUIDES COVERING SYMPTOMS, RISK FACTORS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIAL RESOURCES, SIDE EFFECTS, AFTER TREATMENT, CURRENT RESEARCH AND QUESTIONS TO ASK THE DOCTOR), ASCO ANSWERS FACT SHEETS (A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC, INCLUDING AN OVERVIEW, AN ILLUSTRATION OF WHERE IT STARTS, HOW IT IS TREATED, TERMS TO KNOW, QUESTIONS TO ASK THE DOCTOR, BOOKLETS ON ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, AND CANCER IN OLDER ADULTS.ADDITIONAL RESOURCES AVAILABLE ON CANCER.NETFIND AN ONCOLOGIST DATABASE: A FREE SEARCHABLE DATABASE OF ASCO MEMBERS BY SPECIALTY OR LOCATION FOR THOSE IN NEED OF A SPECIALIST.CANCER ADVANCES: SUMMARIES OF RESEARCH ADVANCES IN CLINICAL ONCOLOGY FROM THE JOURNAL OF CLINICAL ONCOLOGY, ASCO'S ANNUAL MEETINGS, ASCO SYMPOSIA, AND ASCO'S MEET THE EXPERTS EVENTS.WHAT TO KNOW - ASCO'S GUIDELINES: PATIENT-FRIENDLY GUIDES BASED ON ASCO'S CLINICAL PRACTICE GUIDELINES FOR PHYSICIANS.RESEARCH AND MEETINGS: INFORMATION ON ASCO'S CLINICAL CANCER ADVANCES REPORT, ASCO'S ANNUAL MEETINGS AND SYMPOSIA, VIRTUAL LECTURES, AND ASCO'S EXPERT PERSPECTIVE ON CANCER NEWS. MULTIMEDIA: MEDICAL ILLUSTRATIONS, VIDEOS, AND PODCASTS ON TOPICS SUCH AS: CANCER RESEARCH, TREATMENT, AND COPING.EXPERT INFORMATION FROM ASCO: ASCO EXPERTS ANSWER QUESTIONS ABOUT CURRENT TOPICS IN CANCER CARE, TREATMENT, AND RESEARCH.CANCER.NET FEATURE ARTICLES: WEEKLY ARTICLES DESIGNED TO PROVIDE IN-DEPTH INFORMATION ON TOPICS OF INTEREST, AS WELL AS PRACTICAL INFORMATION ON CANCER CARE AND TREATMENT.ASCO CANCER TREATMENT SUMMARY FORMS: PRINTABLE FORMS PATIENTS AND THEIR DOCTORS CAN COMPLETE TO HELP KEEP TRACK OF TREATMENT PLANS AND FOLLOW-UP CARE PLANS.CANCER.NET EN ESPANOL: TRANSLATED CONTENT ON THE TREATMENT OF COMMON CANCER TYPES, MANAGING SIDE EFFECTS, AN INTRODUCTION TO CLINICAL TRIALS, AND ASCO'S GUIDELINES. 3206791 344075 10574306 54559835 1 1 0 1 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 1 1 1 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 420 0 304 1 1 1 1 BD CJ 0 0 0 0 0 0 0 0 X 18 16 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 VA NY X PAUL AINES CPA CFO 5714831300 2318 MILL ROAD 800 ALEXANDRIA VA 22314 GEORGE SLEDGE MD 08-10 1.00 X X 0 0 0 MICHAEL LINK MD 10-13 1.00 X X 20500 0 0 CLIFFORD HUDIS MD 09-12 1.00 X 15000 0 0 JAMES ABBRUZZESE MD 1.00 X X 0 0 0 MONICA BERTAGNOLLI MD 1.00 X 0 0 0 EDUARDO CAZAP MD 1.00 X 0 0 0 SUSAN COHN MD 1.00 X 500 0 0 BRUCE JOHNSON MD 1.00 X 0 0 0 ROBERT LANGDON MD 1.00 X 0 0 0 LORI PIERCE MD 1.00 X 750 0 0 LYNN SCHUCHTER MD 1.00 X 1500 0 0 FRANCES SHEPHERD MD 1.00 X 0 0 0 SANDRA SWAIN MD 1.00 X 0 0 0 EVERETT VOKES MD 1.00 X 3500 0 0 JULIE VOSE MD 1.00 X 0 0 0 PETER YU MD 1.00 X 2000 0 0 ROBIN ZON 1.00 X 0 0 0 DOUGLAS BLAYNEY MD 08-10 1.00 X 2500 0 0 GEORGE SLEDGE MD 08-10 1.00 X 0 0 0 RICHARD SCHILSKY MD08-10 1.00 X 0 250 0 DEAN BAJORIN MD 1.00 X 0 0 0 ROBERT MILLER MD 1.00 X 2500 0 0 KATHLEEN PRITCHARD MD 1.00 X 0 0 0 DEBORAH SCHRAG MD 1.00 X 500 0 0 JOEL TEPPER MD 1.00 X 0 0 0 ALLEN LICHTER MD 37.50 X 758456 0 18656 DINA MICHELS ESQ 37.50 X 447958 0 31884 PAUL AINES CPA 37.50 X 265394 0 32122 NANCY DALY MSMPH 37.50 X 194770 0 25874 JEAN COLVARD 37.50 X 210948 0 21666 DEBORAH KAMIN RNPHD 37.50 X 222989 0 31734 BERNIE KHOO 37.50 X 319620 0 32122 CARA MOLINARI 37.50 X 154714 0 17305 THERESA VAN SCHAIK 37.50 X 162288 0 23318 SUZANNE BRACH 37.50 X 192514 0 25683 KRISTIN LUDWIG 37.50 X 215504 0 17391 KAY NOLL 37.50 X 185828 0 19742 DOUGLAS PYLE 37.50 X 175823 0 28116 LINDA C SCHMIDT 37.50 X 199394 0 14955 3755450 250 340568 30 0 1 0 ASTUTE TECHNOLOGY 11718 BOWMEN GREEN DR RESTON VA 20190 VIDEO RECORDING 748727 POLSINELLI SHUGHART PC 1152 15TH STREET NW WASHINGTON DC 20005 LEGAL 318270 BECKSTEIN PRODUCTION LLC 12415 ROUSSEAU TERRACE NORTH POTOMAC MD 20878 CREATIVE DEVELOPMENT 253950 MCDERMOTT WILL & EMORY LLP 28 STATE STREET BOSTON MA 02109 LEGAL 244009 BRYAN CAVE LLP PO BOX 503089 ST LOUIS MO 63150 LEGAL 170444 11 8931139 8931139 EDUCATION MTGS & PROD 900099 23576502 23376707 199795 MEMBERSHIP 900099 10574316 10574316 PUBLICATIONS 511190 10386506 10386506 EXHIBITS 900099 9801143 9801143 ADVERTISING 541800 9340914 9340914 6720091 6720091 70399472 417115 417115 822 822 116654 116654 211145 1365492 -1154347 -1154347 -1154347 11904058 29618 11589678 314380 29618 343998 343998 MAILING LIST 511120 410190 410190 OTHER 900099 89950 18225 71725 500140 79554993 60858763 8404587 1360504 1190169 1190169 124500 124500 452082 452082 2971818 1196704 1554470 220644 18450273 12920142 3680539 1849592 1277933 905914 272615 99404 2350040 1689906 459329 200805 1374046 941532 325718 106796 662580 391836 270744 101100 101100 148210 148210 193150 193150 174744 174744 10301696 7411248 2890448 236836 203407 33429 728928 470390 256915 1623 1828574 1318083 510491 4319675 3219347 1100328 2378013 1930871 435272 11870 8663009 8193312 469697 2261936 1695407 513052 53477 368932 147081 221851 UBI TAX 1440149 1440149 PRINTING & PRODUCTION 4985927 4917883 67657 387 POSTAGE & SHIPPING 1876824 1845410 31414 BANK & CC FEES 1107017 1028343 78674 TAX UNRELATED TO UBI 426777 329746 97031 -558373 448163 -1006536 69836565 54559835 12538982 2737748 300 300 8629628 5337194 4314452 4349645 3399994 3940777 66398822 7272334 60399106 59126488 50082017 75988397 12773000 7274631 405662 1818474 140004159 157835906 3839291 4913286 15121696 15358538 48050000 48050000 23423460 25636029 90434447 93957853 X 49569712 63878053 49569712 63878053 140004159 157835906 X 9718428 4589913 X X 0 1 1 X 0 X 10019866 2928249 9732535 9749125 8931139 41360914 52328773 8421317 55457162 54860215 58117275 229184742 291953 89689 257198 155397 235462 1029699 62640592 11439255 65446895 64764737 67283876 271575355 14233783 3589400 11825034 11459125 10056139 51163481 0 14233783 3589400 11825034 11459125 10056139 51163481 220411874 2585211 700422 2234994 1248387 848971 7617985 3328558 1418830 1237990 1445377 2794100 10224855 5913769 2119252 3472984 2693764 3643071 17842840 1434494 661354 2444918 2303656 2884051 9728473 69988855 14219861 71364797 69762157 73810998 299146668 0.73680 0.72370 0.05960 0.06330 X SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: CHANGE IN FISCAL YEAR REPORTING: ASCO'S 2007 REPORTED FIGURES REPRESENT THE FINANCIAL TRANSACTIONS FROM ASCO'S SHORT-YEAR PERIOD OF SEPTEMBER 1 - DECEMBER 31, 2007. THIS SHORT-YEAR REPRESENTS A TRANSITIONAL REPORTING PERIOD FOR ASCO FROM A FISCAL YEAR END OF AUGUST 31ST TO A CALENDAR FISCAL YEAR. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 148210 148210 63999451 64147661 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 20258 181000 152632 148210 502100 250000 250000 250000 250000 1000000 1500000 0 0 214 0 214 0 0 15916 15916 0.00000 0.00000 0.00000 7342677 7342677 47944341 2989568 44954773 11111804 4282766 6829038 59126488 DUE TO AFFILIATE 1156663 LIABILITY UNDER INTEREST RATE SWAP AGREEMENT 8529366 TAXABLE BOND PAYABLE 15950000 25636029 79554993 69836565 9718428 4589913 4589913 14308341 85510398 4589913 1365492 5955405 79554993 0 79554993 71202057 1365492 1365492 69836565 0 69836565 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2007 THROUGH 2010 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE TO PART VIII 1,365,492. PART XIII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE TO PART VIII 1,365,492. 1 NORTH AMERICA 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATIONAL AWARD (IDEA), BEST OF ASCO INTERNATIONAL (BOA INT'L) 6845 CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES INTERNATIONAL DEVELOPMENT AND LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. 11363 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L 86204 RUSSIA AND NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATIONAL AWARD (IDEA) 5546 EUROPE 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L 93633 SOUTH AMERICA 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES, MULTIDISCIPLINARY CANCER MANAGEMENT COURSE 74980 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES 60189 MIDDLE EAST & NORTH AFRICA 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. OUTREACH AND JOINT SYMPOSIA, IDEA, BOA INT'L, ADVANCED CANCER COURSES, MULTIDISCIPLINARY CANCER MANAGEMENT COURSE 43406 SOUTH ASIA 0 0 PROGRAM SERVICES LICENSING AND OTHER PROVISION OF CONTENT FOR INTERNATIONAL CANCER EDUCATIONAL PROGRAMS. INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD, INTERNATIONAL AWARDS COMMITTEE 36301 0 0 0 382166 36301 418467 X EUROPE CONTRIBUTION TO JOINT METHODS IN CLINICAL CANCER RESEARCH WORKSHOP 33615 0 1 INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD NORTH AMERICA 1 1200 CHECK 3623 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT CENTRAL AMERICA AND THE CARIBBEAN 1 1200 CHECK 3623 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD EAST ASIA AND THE PACIFIC 7 8400 CHECK 25359 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD RUSSIA AND NEWLY INDEPENDENTS STATES 1 1200 CHECK 3623 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD EUROPE 3 3600 CHECK 10868 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD SOUTH AMERICA 2 2400 CHECK 7245 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD SUB-SAHARAN AFRICA 2 2400 CHECK 7245 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD MIDDLE EAST & AFRICA 2 2400 CHECK 7245 TRAVEL COST BOOK INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD SOUTH ASIA 4 4800 CHECK 14491 TRAVEL COST BOOK 0 0 0 0 0 0 0 GRAHAM PELTON CONSULTING 39 BEECHWOOD RD SUMMIT NJ 07901 FUNDRAISING CONSULTANT 0 0 193150 -193150 193150 -193150 VA NY EXPLANATION OF FUNDRAISING PAYMENTS SCHEDULE G, PART I, LINE 2B, COLUMN (V) PAYMENTS TO GRAHAM PELTON AND MERZ GROUP WERE FOR FUNDRAISING SERVICES FOR ASCO'S 501(C)(3) AFFILIATE, CONQUER CANCER FOUNDATION TO DETERMINE FUNDRAISING BEST PRACTICES - NO REVENUE WAS RECEIVED. 1 AMERICAN SOCIETY OF CONSULTANT PHARMACISTS (ASCP) 1321 DUKE STREET ALEXANDRIA VA 22314 520942322 501(C)(6) 5000 CONTRIBUTION FRIENDS OF CANCER RESEARCH 3299 K ST NW WASHINGTON DC 20007 521983273 501(C)(3) 30675 CONTRIBUTION AMERICAN COLLEGE OF SURGEONS 633 NORTH ST CLAIR CHICAGO IL 60611 362192800 501(C)(3) 50000 CONTRIBUTION ASSOCIATION OF AMERICAN CANCER INST MEDICAL ART BLDG PITTSBURGH PA 15213 237410581 501(C)(3) 5000 CONTRIBUTION BROOKINGS INSTITUTION 1775 MASSACHUSETTS AVE WASHINGTON DC 20036 530196577 501(C)(3) 10000 CONTRIBUTION WASHINGTON STATE MEDICAL ONCOLOGY SOC 113 W 7TH ST STE 205 VANCOUVER WA 98660 562367855 501(C)(6) 5000 CONTRIBUTION KANSAS SOCIETY CLINICAL ONCOLOGY 9200 INDIAN CREEK PKWY SUITE 300 OVERLAND PARK KS 62210 481160355 501(C)(6) 5000 CONTRIBUTION WEST VIRGINIA ONCOLOGY SOCIETY 211 MARION SQUARE PO BOX 2990 FAIRMONT WV 26554 262558397 501(C)(4) 10000 CONTRIBUTION ALABAMA CANCER CONGRESS 8805 N 145TH E AVE STE 203 OWASSO OK 74055 262900861 501(C)(6) 10000 CONTRIBUTION NORTHERN NEW ENGLAND CLINICAL ONCOLOGY SOCIETY PO BOX 643 C/O L AUBREY SANDOWN NH 03873 020445055 501(C)(3) 5000 CONTRIBUTION DUKE CANCER CENTER 2424 ERWIN RD SUITE 601 DURHAM NC 27705 560532129 501(C)(3) 25000 CONTRIBUTION PREVENT CANCER FOUNDATION 1600 DUKE ST 500 ALEXANDRIA VA 22314 521429544 501(C)(3) 11000 CONTRIBUTION CANCERCARE 275 7TH AVE NEW YORK NY 10001 131825919 501(C)(3) 25500 CONTRIBUTION BREAST CANCER RESEARCH FOUNDATION 654 MADISON AVE 1209 NEW YORK NY 10021 133727250 501(C)(3) 30000 CONTRIBUTION NATIONAL COALITION FOR CANCER SURVIVORSHIP 1010 WAYNE AVE 770 SILVER SPRING MD 20910 850357897 501(C)(3) 75000 CONTRIBUTION KOMEN NAT'L RACE FOR THE CURE 1911 N FORT MYER DR 112 ARLINGTON VA 22209 751835298 501(C)(3) 50530 CONTRIBUTION ALEXANDRIA OFFICE ON WOMEN 421 KING ST ALEXANDRIA VA 22341 541780375 501(C)(3) 5000 CONTRIBUTION ANIMAL WELFARE LEAGUE OF ALEXANDRIA 4101 EISENHOWER AVENUE ALEXANDRIA VA 22304 540796610 501(C)(3) 5000 CONTRIBUTION CONQUER CANCER FOUNDATION 2318 MILL ROAD 800 ALEXANDRIA VA 22314 311667995 501(C)(3) 90568 CONTRIBUTION FRED HUTCHINSON CANCER CENTER 110 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 20900 CONTRIBUTION INTERNATIONAL UNION AGAINST CANCER 500 FIFTH ST NW WASHINGTON DC 20001 237208844 501(C)(3) 44380 CONTRIBUTION MEMORIAL SLOAN KETTERING CANCER CENTER PO BOX 026338 NEW YORK NY 10087 131924236 501(C)(3) 46037 CONTRIBUTION INDIANA UNIVERSITY 620 UNION DRIVE INDIANAPOLIS IN 46202 356001673 501(C)(3) 142549 CONTRIBUTION STANFORD UNIVERSITY 1000 WELCH ROAD 301 STANFORD CA 94301 941156365 501(C)(3) 53631 CONTRIBUTION UNIVERSITY OF MICHIGAN 3003 S STATE STREET ANN ARBOR MI 48109 386006309 501(C)(3) 83200 CONTRIBUTION UNIVERSITY OF CHICAGO 5801 SOUTH ELLIS AVE CHICAGO IL 60637 362177139 501(C)(3) 10400 CONTRIBUTION AMERICAN CANCER BIOREPOSITORY INC 201 E JEFFERSON STREET LOUISVILLE KY 40202 141843303 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM CANCER CARE ASSOCIATES MEDICAL GROUP INC 514 N PROSPECT AVE 4TH FL REDONDO BEACH CA 90277 330004735 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM DREYER CANCER CTR 1221 N HIGHLAND AVE AURORA IL 60506 362690329 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM HEMATOLOGY ONCOLOGY ASSOC IL 676 N ST CLAIR CHICAGO IL 60611 364117454 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM IOWA CANCER CARE ONCOLOGY ASSOCIATES 525 10TH ST SE CEDAR RAPIDS IA 52403 421203658 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM LOUISIANA ONCOLOGY SOCIETY 501 W ST MARY BLVD SUITE 200 LAFAYETTE LA 70506 721188733 501(C)(3) 6500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM MAINE GENERAL MEDICAL CTR 361 OLD BELGRADE ROAD AUGUSTA ME 04330 043369653 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM NEW YORK HOSP QUEENS 56-26 MAIN ST FLUSHING NY 11355 112638852 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM NORTHWEST MEDICAL SPEC PLLC 1624 SOUTH I STREET TACOMA WA 98405 911867315 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM ONCOLOGY ALLIANCE SC 1055 N MAYFAIR RD WAUWATOSA WI 53226 391225006 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM PALO ALTO MEDICAL FOUNDATION 795 EL CAMINO REAL PALO ALTO CA 94301 941156581 501(C)(3) 6500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM PIKEVILLE MEDICAL CENTER INC 911 BYPASS ROAD PIKEVILLE KY 41501 610458376 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM RAMAN SOOD PHYSICIAN PC 617 CENTRAL AVE DUNKIRK NY 14048 161059338 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM SIMONDS-SINON REGIONAL 275 NICHOLS ROAD FITCHBURG MA 01420 042103555 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM SOUTHFIELD ONCOLOGY INST INC 21751 WEST ELEVEN MILE ROAD SOUTHFIELD MI 48076 382851003 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM THE MIRIAM HOSPITAL 164 SUMMIT AVE PROVIDENCE RI 02906 050258905 501(C)(3) 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM WENATCHEE VALLEY MED CTR PS 820 N CHELAN WENATCHEE WA 98801 910647181 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM WEST CLINIC PC 100 N HUMPHREYS BLVD MEMPHIS TN 38120 621526296 N/A 13500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM 29 15 SCIENCE OF ONCOLOGY AWARD 1 10000 DAVID A KARNOFSKY AWARD 1 25000 BJ KENNEDY AWARD 1 5000 PEDIATRIC ONCOLOGY AWARD 1 5000 GIANNI BONADONNA BREAST CANCER AWARD 1 10000 ASCO / AMERICAN CANCER SOCIETY AWARD 1 10000 DIVERSITY IN ONCOLOGY INITIATIVE WHICH INCLUDED 4 MEDICAL STUDENT ROTATION AWARDS AND 16 RESIDENT TRAVEL AWARDS 20 32500 SUSAN G. KOMEN FOR THE CURE/ASCO QUALITY OF CARE INITIATIVE; BREAST CANCER REGISTRY PILOT PROGRAM 2 27000 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: ASCO GRANTS SEVERAL SPECIAL AWARDS INTENDED TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS WHOSE COMMITMENT TO FURTHERING THE PROGRESS AGAINST CANCER HAS LED TO TREMENDOUS CONTRIBUTIONS TO THE FIELD OF CLINICAL ONCOLOGY, CANCER PATIENTS, AND ASCO. SPECIAL AWARD RECIPIENTS ARE HONORED AT AND MOST GIVE A LECTURE DURING AN ASCO MEETING OR SYMPOSIUM. SPECIAL AWARD RECIPIENTS ARE SELECTED BASED ON A PEER-REVIEW PROCESS USING ELIGIBILITY CRITERIA ESTABLISHED FOR EACH AWARD. FUNDS AWARDED TO SPECIAL AWARD RECIPIENTS ARE GIVEN AS STIPENDS OR PRIZES, NOT FOR SPECIFIC RESEARCH PROJECTS THAT ARE SUBJECT TO REPORTING. DUE TO THE TYPE OF AWARD THERE IS NO FOLLOW UP ON THE USE OF THE FUNDS. THE GIANNI BONADONNA BREAST CANCER AWARD, BREAST CANCER REGISTRY PILOT PROGRAM AND THE DIVERSITY IN ONCOLOGY MEDICAL STUDENT ROTATION PROGRAM ARE REQUIRED TO NOTIFY GRANT SUPPORT STAFF IF THERE ARE SIGNIFICANT DELAYS THAT WILL MATERIALLY AFFECT THE ABILITY TO ATTAIN THE OBJECTIVES OF THE GRANT PROJECT OR TO MEET SUCH TIME SCHEDULES AS MAY HAVE BEEN PROPOSED. GRANTEES ARE REQUIRED TO NOTIFY THE GRANT SUPPORT STAFF IF THEY PLAN TO LEAVE AN ORGANIZATION DURING THE COURSE OF A GRANT AND MUST SUBMIT A REQUEST FOR APPROVAL OF INSTITUTION TRANSFER OF THE GRANT BEFORE ANY TRANSFER TAKES PLACE. THE GRANT SUPPORT STAFF REQUIRES TECHNICAL PROJECT REPORTS (PROGRESS REPORTS) AND BUDGET SUMMARIES (FINANCIAL REPORTS) FOR ALL GRANTS. UNLESS OTHERWISE SPECIFIED IN THE GRANT TERMS AND CONDITIONS, AN ANNUAL PROGRESS REPORT AND A BUDGET SUMMARY ARE REQUIRED TO BE SUBMITTED WITHIN 30 DAYS FOLLOWING THE END OF THE GRANT BUDGET PERIOD. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. THE GRANT SUPPORT STAFF REQUIRES A FINAL PROJECT REPORT AND BUDGET SUMMARY WITHIN 30 DAYS FOLLOWING EXPIRATION OF THE GRANT. THE GRANT SUPPORT STAFF REVIEWS THE REPORTS AND IF APPROVED, PROVIDES THE GRANTEE AN APPROVAL NOTIFICATION. ALL UNUSED FUNDS AT THE END OF THE AWARD TERM MUST BE RETURNED. GRANTS ARE ADMINISTRATIVELY CLOSED BY THE GRANT SUPPORT STAFF AFTER RECEIPT OF THE FINAL PROJECT REPORT AND FINAL BUDGET SUMMARY AND AFTER THE GRANT SUPPORT STAFF'S DETERMINATION THAT ANY OTHER ADMINISTRATIVE REQUIREMENTS IN THE GRANT HAVE BEEN MET. THE GRANT SUPPORT STAFF RESERVES THE RIGHT TO ASK THE GRANTEE TO RETURN FUNDS THAT WERE SPENT INCONSISTENTLY WITH THE APPROVED BUDGET. X 1 1 X X X X X X 0 1 0 0 0 0 0 1 1 1 ALLEN LICHTER MD 606893 0 91563 0 60000 0 0 0 18656 0 777112 0 0 0 DINA MICHELS ESQ 445244 0 0 0 2714 0 0 0 31884 0 479842 0 0 0 PAUL AINES CPA 261394 0 4000 0 0 0 0 0 32122 0 297516 0 0 0 NANCY DALY MSMPH 194770 0 0 0 0 0 0 0 25874 0 220644 0 0 0 JEAN COLVARD 207948 0 3000 0 0 0 0 0 21666 0 232614 0 0 0 DEBORAH KAMIN RNPHD 218989 0 4000 0 0 0 0 0 31734 0 254723 0 0 0 BERNIE KHOO 305620 0 14000 0 0 0 0 0 32122 0 351742 0 0 0 CARA MOLINARI 154714 0 0 0 0 0 0 0 17305 0 172019 0 0 0 THERESA VAN SCHAIK 159788 0 2500 0 0 0 0 0 23318 0 185606 0 0 0 SUZANNE BRACH 189514 0 3000 0 0 0 0 0 25683 0 218197 0 0 0 KRISTIN LUDWIG 210504 0 5000 0 0 0 0 0 17391 0 232895 0 0 0 KAY NOLL 181828 0 4000 0 0 0 0 0 19742 0 205570 0 0 0 DOUGLAS PYLE 172823 0 3000 0 0 0 0 0 28116 0 203939 0 0 0 LINDA C SCHMIDT 199394 0 0 0 0 0 0 0 14955 0 214349 0 0 0 PART I, LINE 1A A HOUSING ALLOWANCE IS PROVIDED TO THE CEO, WHICH IS CONSIDERED PART OF THE CEO'S COMPENSATION AND ADDRESSED IN THE CEO'S WRITTEN EMPLOYMENT CONTRACT. THE HOUSING ALLOWANCE IS TREATED AS TAXABLE COMPENSATION. PART I, LINE 4B CONTRIBUTIONS TO 457(B) PLAN: ALLEN LICHTER $16,500 JEAN COLVARD $16,500 PART I, LINE 7 PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE. PART I, LINE 8 CERTAIN AMOUNTS PAID OR ACCRUED TO THE CEO AND THE VP/GC WERE PURSUANT TO A CONTRACT THAT WAS SUBJECT TO THE INITIAL CONTRACT EXCEPTION DESCRIBED IN TREAS. REGS. SECTION 53.4958-4(A)(3). INDUSTRIAL DEVELOPMENT AUTHORITY CITY OF ALEXANDRIA 521381432 01530LAD2 2008-04-23 48050000 BUY/BLDOUT 5 FLS HQ BLDG 0 0 0 48050000 60538 47262589 787411 2008 0 0 0 1 0 0 0 0 1 1 0 1 1 DEPFA BANK 30.000000000000 0 0 0 0 0 PART IV, QUESTION 3: ASCO HAS AN INTEREST RATE SWAP AGREEMENT WITH DEPFA BANK THROUGH 2038. ASCO MAKES FIXED INTEREST PAYMENTS AT A 3.587% RATE. VARIABLE SWAP PAYMENTS, BASED ON ONE-MONTH LIBOR, RECEIVED FROM THE SWAP COUNTERPARTY ARE USED TO MAKE THE VARIABLE INTEREST PAYMENTS AS THEY COME DUE. THESE INTEREST RATE SWAP AGREEMENTS QUALIFY AS A DERIVATIVE INSTRUMENT AND ARE USED TO MITIGATE THE EFFECT OF INTEREST RATE FLUCTUATIONS. NEW PROGRAM SERVICES FORM 990, PART III, LINE 2 ASCO'S QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) IS AN ONCOLOGIST-LED, PRACTICE-BASED QUALITY IMPROVEMENT PROGRAM. NEW IN 2010 IS ASCO'S QOPI CERTIFICATION PROGRAM WHICH BUILDS UPON THE SUCCESS OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE. THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO: -- PROMOTE HIGH QUALITY CANCER CARE AS DEFINED BY THE CLINICIAN EXPERTS. -- PROVIDE A TRUSTED SOLUTION TO SATISFY EXTERNAL DEMAND FOR QUALITY ACTIVITIES. -- REDUCE REDUNDANT PROGRAMS OR ADMINISTRATIVE BURDENS FOR ONCOLOGY PRACTICES, INCLUDING HEALTH PLAN PROGRAMS. THE QOPI CERTIFICATION PROGRAM IS CARRIED OUT BY A SPECIAL-PURPOSE LIMITED LIABILITY COMPANY LIMITED LIABILITY CORPORATION (LLC), THE INSTITUTE OF CLINICAL EXCELLENCE, THE INSTITUTE OF CLINICAL EXCELLENCE, LLC INCLUDES THE TRADE NAME QOPI CERTIFICATION PROGRAM. THE SOLE MEMBER OF THIS LLC IS ASCO AND THE ACTING MANAGER IS ASCO'S CHIEF EXECUTIVE OFFICER. FORM 990, PART VI, SECTION A, LINE 1 AS OF DECEMBER 31, 2010, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH VOTING RIGHTS: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND 14 DIRECTORS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS ARE ELECTED BY VOTING MEMBERS OF ASCO AND HAVE THE SAME VOTING RIGHTS. THE CHIEF EXECUTIVE OFFICER (CEO) IS AN EX-OFFICIO, NON-VOTING MEMBER OF THE BOARD OF DIRECTORS. DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. DURING THE REPORTING YEAR, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE WERE: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND THOSE DIRECTORS SERVING THEIR FINAL YEAR OF THEIR TERM. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS. FORM 990, PART VI, SECTION A, LINE 6 ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. THE CATEGORIES OF MEMBERSHIP AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. ACTIVE MEMBERS. 1.A. ACTIVE MEMBERS ARE EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. 1.B. RIGHTS OF ACTIVE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE AND HOLD OFFICE IN ASCO. 2. INTERNATIONAL CORRESPONDING MEMBERS. 2.A. INTERNATIONAL CORRESPONDING MEMBERS ARE EXPERIENCED PHYSICIANS WHO ARE ELIGIBLE TO BE ACTIVE MEMBERS, BUT WHO RESIDE IN A DEVELOPING NATION OR A NATION WITH A LOW PER-CAPITA INCOME, AS DEFINED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. 2.B. RIGHTS OF INTERNATIONAL CORRESPONDING MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. INTERNATIONAL CORRESPONDING MEMBERS MAY NOT SERVE ON COMMITTEES OF ASCO, AND MAY NOT VOTE OR HOLD OFFICE IN ASCO. 3. ACTIVE-ALLIED MEMBERS. 3.A. ACTIVE-ALLIED MEMBERS ARE OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANK WHO ARE NOT ELIGIBLE TO BE AN ACTIVE MEMBER AND WHO HAVE A PREDOMINANT INTEREST IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 3.B. RIGHTS OF ACTIVE-ALLIED MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND TO SERVE ON ALL COMMITTEES OF ASCO. ACTIVE-ALLIED MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 4. AFFILIATE MEMBERS. 4.A. AFFILIATE MEMBERS ARE ONCOLOGY NURSES, PHYSICIAN ASSISTANTS, AND OTHER HEALTH SPECIALISTS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO THE CARE AND TREATMENT OF PATIENTS WITH NEOPLASTIC DISEASES. MEMBERSHIP IS LIMITED TO THOSE PARAMEDICAL PERSONNEL WHO FUNCTION AS INTEGRAL MEMBERS OF A TEAM OF ONCOLOGISTS RESPONSIBLE FOR THE CARE OF SUCH PATIENTS OR WHO ENGAGE IN THE CONDUCT OF CLINICAL TRIALS. ELECTION TO MEMBERSHIP IS BASED ON EXPERIENCE IN AND CONTRIBUTIONS TO THE FIELD OF ONCOLOGY. ADDITIONALLY, AFFILIATE MEMBER STATUS INCLUDES INDIVIDUALS WHO HOLD LEADERSHIP POSITIONS OR HAVE TAKEN A DISTINGUISHED LEADERSHIP ROLE IN A NATIONALLY OR INTERNATIONALLY RECOGNIZED NOT-FOR-PROFIT, TAX-EXEMPT ORGANIZATION DEDICATED TO CANCER PATIENT ADVOCACY OR SURVIVORSHIP. 4.B. RIGHTS OF AFFILIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND SERVE ON ALL COMMITTEES OF ASCO. AFFILIATE MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 5. EMERITUS MEMBERS. 5.A. EMERITUS MEMBERS ARE ACTIVE, ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING AND AFFILIATE MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 65, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 5.B. RIGHTS OF EMERITUS MEMBERS INCLUDE BEING EXEMPT FROM MEMBERSHIP DUES. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE ACTIVE MEMBERS RETAIN ALL RIGHTS AND PRIVILEGES OF ACTIVE MEMBER STATUS, EXCEPT THE HOLDING OF OFFICE. EMERITUS MEMBERS WHO WERE PREVIOUSLY ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBERS RETAIN ALL THE RIGHTS AND PRIVILEGES OF ACTIVE-ALLIED, INTERNATIONAL CORRESPONDING OR AFFILIATE MEMBER STATUS RESPECTIVELY. 6. HONORARY MEMBERS. 6.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 6.B. RIGHTS OF HONORARY MEMBERS INCLUDE HAVING ALL PRIVILEGES OF ACTIVE MEMBERS, EXCEPT THEY MAY NOT HOLD OFFICE AND ARE EXEMPT FROM PAYING MEMBERSHIP DUES. 7. ASSOCIATE MEMBERS. 7.A. ASSOCIATE MEMBERS ARE HEALTH PROFESSIONALS HAVING AN MD, DO, PHD, PHARMD, OR OTHER DOCTORAL DEGREE, WHO ARE PARTICIPATING IN A SUBSPECIALTY TRAINING PROGRAM IN ONCOLOGY OR ANOTHER FIELD THAT WOULD LEAD TO ELIGIBILITY FOR ACTIVE OR ACTIVE-ALLIED MEMBERSHIP. 7.B. RIGHTS OF ASSOCIATE MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. ASSOCIATE MEMBERS MAY NOT HOLD OFFICE OR VOTE, EXCEPT THAT THEY MAY SERVE AS VOTING MEMBERS OF COMMITTEES OF ASCO. FORM 990, PART VI, SECTION A, LINE 7A VOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS: THE PRESIDENT, PRESIDENT-ELECT, PAST-PRESIDENT, TREASURER, AND 14 DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS. FORM 990, PART VI, SECTION B, LINE 11 AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE VICE PRESIDENT AND GENERAL COUNSEL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G., SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E., A ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERNATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C) (3) TAX-EXEMPT AFFILIATE, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION); THE PRESIDENT OF INSTITUTE OF CLINICAL EXCELLENCE, LLC (D/B/A QOPI CERTIFICATION PROGRAM); AND THE PRESIDENT OF ASCO LEASING, LLC. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW, RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. COMPENSATION OF CERTAIN OFFICERS AND KEY EMPLOYEES OF ASCO VICE PRESIDENT/ GENERAL COUNSEL: THE COMPENSATION OF THE VICE PRESIDENT/GENERAL COUNSEL (VP/GC) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE VP/GC WAS REASONABLE. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE VP/GC AND ASCO ADDRESSES COMPENSATION OF THE VP/GC. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP/GC BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. CHIEF FINANCIAL OFFICER (CFO): THE COMPENSATION OF THE CHIEF FINANCIAL OFFICER (CFO) WAS CONSIDERED AND APPROVED BY THE COMPENSATION COMMITTEE, AFTER CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CFO WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CFO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. EXECUTIVE DIRECTOR OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION): THE EXECUTIVE DIRECTOR OF CCF IS AN EMPLOYEE OF ASCO. THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2010. SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY: THE COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY AFTER RECEIVING THE RECOMMENDATIONS OF THE CEO AND THE ADVICE OF INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY BASED ON THE ABOVE DESCRIBED PROCESS WERE UNDERTAKEN IN 2010. FORM 990, PART VI, SECTION C, LINE 19 ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, WAS PUBLISHED IN THE JANUARY 20, 2006 EDITION OF JOURNAL OF CLINICAL ONCOLOGY (THE EDITION IS AVAILABLE TO THE PUBLIC FOR FREE), AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. FORM 990, PART VI, SECTION A, LINE 7B: NO DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO APPROVAL BY MEMBERS, STOCKHOLDERS, OR OTHER PERSONS. HOWEVER, THE BYLAWS MAY ONLY BE AMENDED AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED BY VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: ACTIVE MEMBERS; EMERITUS MEMBERS WHO WERE ACTIVE MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS; AND HONORARY MEMBERS. FORM 990, PART VI, SECTION B, LINE 10B: ALTHOUGH ASCO HAS STATE AND REGIONAL AFFILIATES THROUGH ITS STATE AND REGIONAL AFFILIATE PROGRAM, ASCO DOES NOT HAVE THE LEGAL AUTHORITY TO EXERCISE SUPERVISION AND CONTROL OVER THEM AND EACH AFFILIATE IS A SEPARATELY INCORPORATED LEGAL ENTITY THAT IS RESPONSIBLE FOR ITS OWN FISCAL MANAGEMENT. AFFILIATES MAY NOT ACT ON BEHALF OF ASCO AND ARE PROHIBITED FROM ANY ACTION THAT MIGHT IMPLY AN AGENCY RELATIONSHIP. AFFILIATES MAY NOT BIND ASCO TO ANY CONTRACT WITH A THIRD PARTY. ASCO'S STATE AND REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ASSIST STATE AND REGIONAL SOCIETIES IN ADDRESSING THE PRACTICAL ISSUES FACING PHYSICIANS WHO CARE FOR PEOPLE WITH CANCER AND TO FACILITATE AND ENCOURAGE INVOLVEMENT IN ASCO'S PUBLIC POLICY INITIATIVES. EACH AFFILIATE HAS A VOTING REPRESENTATIVE ON THE ASCO CLINICAL PRACTICE COMMITTEE (CPC), WHICH IS INTENDED TO ADDRESS THE INTERESTS OF PRACTICING ONCOLOGISTS, WITH A PARTICULAR FOCUS ON REIMBURSEMENT FOR, ACCESS TO, AND QUALITY OF MEDICAL ONCOLOGY SERVICES. THROUGH PARTICIPATION IN THE CPC, AFFILIATES HAVE A ROLE IN THE DEVELOPMENT OF PUBLIC POLICY POSITIONS AT THE NATIONAL LEVEL AND ASCO RECEIVES INPUT REGARDING STATE AND REGIONAL ISSUES AFFECTING ONCOLOGY. STATE AND REGIONAL SOCIETIES INTERESTED IN BEING AFFILIATES MUST SUBMIT AN APPLICATION TO ASCO THAT, AMONG OTHER THINGS, REQUIRES THEM TO DEMONSTRATE THAT THEY ARE VALIDLY INCORPORATED UNDER STATE LAW, HAVE IN PLACE GOVERNANCE PRACTICES AND PROCEDURES (BYLAWS, OFFICERS, DIRECTORS, ELECTIONS, MEETINGS, AND RESPONSIBLE FISCAL MANAGEMENT) AND HAVE PHYSICIAN MEMBERSHIP REQUIREMENTS THAT ARE CONSISTENT WITH ASCO'S STANDARDS. ASCO PROVIDES STATE AFFILIATES WITH A VARIETY OF ASSISTANCE, INCLUDING ASCO POLICY ANALYSES, ACCESS TO ASCO STAFF ON MATTERS OF INTEREST TO STATE AFFILIATES, AND ASSISTANCE WITH MEDIA AND OUTREACH. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 4,589,913. FORM 990. PART XII, LINE 2C: THERE HAS BEEN NO CHANGE IN THE PROCESS FROM THE PREVIOUS YEAR. ASCO HAS AN AUDIT COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT REVIEW. INSTITUTE OF CLINICAL EXCELLENCE LLC 2318 MILL ROAD ALEXANDRIA VA 22314 271629211 QOPI CERTIFICATION PROGAM VA 31631 36053 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ASCO LEASING LLC 2318 MILL ROAD ALEXANDRIA VA 22314 273378225 RENTAL OF 5TH FLOOR VA 211145 289206 AMERICAN SOCIETY OF CLINICAL ONCOLOGY CONQUER CANCER FOUNDATION OF ASCO (CCF) 2318 MILL ROAD ALEXANDRIA VA 22314 311667995 DEDICATED TO CONQUERING CANCER WORLDWIDE BY FUNDING RESEARCH VA 501 (C)(3) 509 (A)(1) 1 1 1 1 0 1 0 0 0 1 0 0 1 0 1 1 1 0 0 CCF A 211536 CCF B 813607 CCF C 8931139 CCF E 64715398 CCF I 211536 CCF L 2933944 CCF N 2477241 CCF O 489823 CCF P 8966365